NSE: LUPIN | BSE: 500257

Mid-range Performer

Download real time

2019.60 -84.50 (-4.02%)

35.24% Gain from 52W Low

747.2K NSE+BSE Volume

NSE 25 Apr, 2025 3:31 PM (IST)

92,207.9

Market Cap

High in industry

0.7

Beta 1Year

Very Low volatility

US FDA Approval

Lupin gets US FDA approval for Tolvaptan Tablets with annual sales of $1.4 bn See details

Lupin Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Lupin Ltd. from all sources in a single place.

Load latest

Is Lupin Ltd. worth buying?

908 Votes:

Buy 72.58%

Sell 17.73%

Hold 9.69%

RESEARCH REPORTS

Hold SEE REPORTS >

Buy SEE REPORTS >